It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).
It was initially intended as a treatment for multiple myeloma. Thalidomide is an accepted therapeutic modality. Thalidomide has also shown efficacy in the class of hematological disorders. These hematological disorders are known as myelodysplastic syndromes (MDS) for multiple myeloma.